News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,007 Results
Type
Article (5092)
Company Profile (24)
Press Release (226891)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82245)
Career Advice (463)
Deals (15055)
Drug Delivery (8)
Drug Development (19073)
Employer Resources (30)
FDA (3682)
Job Trends (3909)
News (120179)
Policy (7513)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (293)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14807)
ALS (38)
Alzheimer's disease (294)
Antibody-drug conjugate (ADC) (40)
Approvals (3782)
Artificial intelligence (80)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2865)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (101)
Cancer (886)
Cardiovascular disease (61)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16682)
Collaboration (353)
Compensation (371)
Complete response letters (8)
COVID-19 (311)
CRISPR (13)
C-suite (339)
Cystic fibrosis (28)
Data (1325)
Denatured (1)
Depression (21)
Diabetes (78)
Diagnostics (2114)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (31)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (35)
Earnings (42737)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39134)
Executive appointments (424)
FDA (4420)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (340)
Gene editing (24)
Generative AI (5)
Gene therapy (102)
GLP-1 (144)
Government (422)
Guidances (197)
Healthcare (5045)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (337)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7881)
IRA (3)
Job creations (1122)
Job search strategy (361)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2337)
Liver cancer (21)
Longevity (2)
Lung cancer (92)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (139)
MASH (50)
Medical device (3918)
Medtech (3928)
Mergers & acquisitions (7579)
Metabolic disorders (214)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (539)
NextGen: Class of 2026 (1674)
Non-profit (730)
Now hiring (5)
Obesity (84)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (51)
Patient recruitment (96)
Peanut (6)
People (25218)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (4994)
Phase 2 (7225)
Phase 3 (5788)
Pipeline (1962)
Policy (17)
Postmarket research (625)
Preclinical (1946)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (179)
Real estate (1886)
Recruiting (8)
Regulatory (5537)
Reports (17)
Research institute (308)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (54)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1017)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (9)
Weight loss (29)
Women's health (6)
Date
Last 7 days (146)
Last 30 days (563)
Last 365 days (8887)
2026 (784)
2025 (9037)
2024 (11030)
2023 (13195)
2022 (18658)
2021 (19678)
2020 (18238)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12120)
2014 (9587)
2013 (7707)
2012 (8330)
2011 (8796)
2010 (8634)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11782)
Australia (1690)
California (3542)
Canada (1138)
China (167)
Colorado (143)
Connecticut (162)
Delaware (70)
Europe (25486)
Florida (541)
Georgia (67)
Idaho (24)
Illinois (161)
India (14)
Indiana (105)
Iowa (9)
Japan (164)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (352)
Massachusetts (2803)
Michigan (104)
Minnesota (201)
Mississippi (1)
Missouri (31)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1018)
New Mexico (5)
New York (814)
North Carolina (479)
North Dakota (4)
Northern California (1854)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (597)
Puerto Rico (1)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1305)
Tennessee (61)
Texas (480)
United States (12329)
Utah (111)
Virginia (84)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
232,007 Results for "genelux corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genelux Corporation Announces Proposed Public Offering of Common Stock
January 8, 2026
·
4 min read
Press Releases
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
January 13, 2026
·
1 min read
Press Releases
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer
January 5, 2026
·
5 min read
Press Releases
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
January 9, 2026
·
4 min read
Press Releases
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
January 5, 2026
·
9 min read
Press Releases
Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference
November 27, 2025
·
1 min read
Press Releases
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates
November 6, 2025
·
9 min read
Press Releases
Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference
September 3, 2025
·
2 min read
Press Releases
Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates
August 8, 2025
·
8 min read
Press Releases
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
July 8, 2025
·
4 min read
1 of 23,201
Next
